Therapeutic Advances in Psychopharmacology
Journal Highlights
- Launched in 2011
- Gold open access journal – all articles are made freely available online immediately upon publication
- Rigorous peer review
- Listed in PubMed and indexed in Web of Science and Science Citation Index Expanded (SCIE)
- Over 1 million full-text article views annually
Therapeutic Advances in Psychopharmacology (TPP) is a peer-reviewed open access journal which focuses on delivering the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of psychopharmacology. Please see the Aims and Scope for further information.
The journal is a member of the Committee on Publication Ethics (COPE).
Diversity, Equity and Inclusion Statement
Therapeutic Advances in Psychopharmacology (TPP) promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the psychopharmacology community.
Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.
We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.
We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.
Submission information
Submit your manuscript today at http://mc.manuscriptcentral.com/tpp
Please see the Submission Guidelines for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that all articles are freely accessible online in perpetuity under a Creative Commons licence.
The APC for this journal is currently 2650 USD. The article processing charge for Plain Language Summary is $4500 USD.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
Contact
Please direct any queries to tpp@sagepub.co.uk
Therapeutic Advances in Psychopharmacology delivers the highest quality peer-reviewed open access articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of psychopharmacology. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in psychopharmacology, providing an online forum for rapid dissemination of recent research and perspectives in this area.
The editors welcome original research articles across all areas of psychopharmacology.
The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.
Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, health economic and pharma-economic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. The trial registry name and URL, and registration number must be included at the end of the abstract.
The journal adheres to a single-anonymised peer review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees.
| Professor David Taylor, PhD FRPharmS FRCPEdin FRCPsych(Hon) | Maudsley Hospital, London, UK & King’s College London, UK |
| Shasha Sharief | SAGE Publishing, London, UK |
| Doctor Mark Horowitz, MBBS, PhD | Research and Development Department at North East London NHS Trust, UK & Department of Psychiatry at University College London, UK |
| Professor James Rucker, MBBS MRCPsych PhD | King’s College London, UK |
| Professor Shuichi Suetani, MB ChB, PhD | Queensland Centre for Mental Health Research, Queensland, Australia |
| Professor Mark Taylor, MBBS; MD; FRCPE; FRCPsych; FRANZCP | Griffith University School of Medicine, Queensland, Australia |
| Professor Ursula Werneke, MD, MSc, PgDip (LSHTM), FRCPsych | Umea University, Umea, Sweden |
| Professor Mahavir Agarwal, MBBS, MD, PhD | University of Toronto, ON, Canada |
| Professor David Baldwin, MA, DM, FRCPsych, FRSA, FHEA | University of Southampton, UK |
| Professor Thomas Barnes, MB BS, MD, FRCPsych, DSc | Imperial College London, UK |
| Professor Antonio Bruno, MD, PhD | Department of Biomedical, Dental Sciences and Morpho-functional Imaging (BIOMORF), University of Messina, Messina, Italy |
| Professor Katharina Domschke, MA, MD, PhD | Universitätsklinikum Freiburg, Germany |
| Professor Adriana Feder, MD | Icahn School of Medicine at Mount Sinai, New York, NY, USA |
| Professor Paul Glue, MD, FRCPsych | University of Otago, Dunedin, New Zealand |
| Professor Gerhard Grobler, MBChB, PhD, MMed (Psychiatry) | Steve Biko Academic Hospital and University of Pretoria, South Africa |
| Professor Peter Haddad, MD, FRCPsych | Barwon Health, Geelong, Victoria, Australia; Deakin University, Geelong, Victoria, Australia |
| Professor Oliver Howes, BM, BCh, MA, MRCPsych, PhD, DM | King's College London, London, UK |
| Professor Eija Kalso, MD, DMed Sci, PhD | University of Helsinki, Finland |
| Professor Deanna L. Kelly, PharmD, BCPP | University of Maryland School of Medicine, Baltimore, MD, USA |
| Professor Tim Lambert, BSc MBBS PhD FRANZCP | Sydney Local Health District, University of Sydney, Collaborative Centre for Cardiometabolic Health in Psychosis (ccCHiP) |
| Professor Anne Lingford-Hughes, PhD | Imperial College London, London, UK |
| Professor Feng Liu, PhD | Tianjin Medical University General Hospital, Tianjin, China |
| Professor Roger S. McIntyre, MD, FRCPC | Professor of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada |
| Professor Jelena Milic, MSc, PhD | National Institute of Public Health, University of Belgrade, Serbia |
| Professor Phil Mitchell, MB BS (Hons I; Syd), MD (UNSW), FRANZCP, FRCPsych | University of New South Wales, NSW, Australia |
| Professor Antônio Egidio Nardi, PhD | Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil |
| Doctor Maxine X. Patel ,MBBS, MSc, MD, FRCPsych | Oxleas NHS Foundation Trust & King's College London, UK |
| Doctor Carol Paton, BSc, DipClinPharm, FCMHP | Imperial College London, UK |
| Doctor Jill Rasmussen, MBChB, FRCGP, FFPM | psi-napse, Dorking, UK |
| Professor Suzanne Reeves, PhD | University College London, UK |
| Professor Mary Seeman, OC, MDCM, DSc | University of Toronto, ON, Canada |
| Professor Dan Siskind, MBBS, MPH, PhD, FRANZCP | The University of Queensland, St Lucia, Queensland, Australia |
| Professor Stephen Stahl, MD, PhD | University of California, San Diego, CA, USA |
| Professor James Stone, MBBS, PhD, FRCPsych | University of Sussex, Brighton, UK & King's College London, UK |
| Professor John Strang, MBBS, MD, FRCPsych, FAcMedSci | King's College London, UK |
| Professor Rajesh Tampi, MD, MS | Yale School of Medicine, New Haven, CT, USA & Creighton University School of Medicine, Omaha, NE, USA |
| Professor Mauricio Tohen, MD, DrPH, MBA | The University of New Mexico, School of Medicine, Albuquerque, USA |
| Professor Michael Travis, MD | University of Pittsburgh, Pittsburg, PA, USA |
| Professor Hiroyuki Uchida, MD, PhD | Keio University Medical School, Tokyo, Japan |
| Professor Eduard Vieta, MD, PhD | University of Barcelona, Barcelona, Spain |
| Professor Nicola Warren, MBBS, PhD | University of Queensland, Australia |
- Clarivate Analytics: Current Contents - Clinical Medicine
- Clarivate Analytics: Current Contents - Life Sciences
- Clarivate Analytics: Science Citation Index Expanded (SCIE)
- Directory of Open Access Journals (DOAJ)
- ProQuest
- PubMed Central (PMC)
- Scopus
Manuscript submission guidelines can be accessed on Sage Journals.